2018
DOI: 10.1111/jopr.12984
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Comparative Evaluation of Nd:YAG Laser and a New Varnish Containing Casein Phosphopeptides‐Amorphous Calcium Phosphate for the Treatment of Dentin Hypersensitivity: A Prospective Study

Abstract: Purpose:The aim of this study was to compare the effect of Nd:YAG laser to that of a new varnish: MI Varnish with RECALDENT (GC), for the treatment of dentin hypersensitivity, with a follow-up of 6 months. Dentinal hypersensitivity was evaluated using a new thermal test never before used on dental tissue. Materials and Methods: A split-mouth design was used where teeth on one side received the same type of treatment. Twelve patients suffering from dentin hypersensitivity were chosen. Fifty-four teeth were divi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
21
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(22 citation statements)
references
References 57 publications
0
21
0
1
Order By: Relevance
“…After duplicate exclusion and abstract screening, 37 studies were left for full‐text evaluation. Thirteen studies (Abed et al, 2012; Bal, Keskiner, Sezer, Acikel, & Saygun, 2015; Chebel, Zogheib, Baba, & Corbani, 2018; Guo, Kayastha, Chen, Shakya, & Chen, 2019; Kara & Orbak, 2009; Kumar & Mehta, 2005; Maximiano et al, 2019; Orhan, Aksoy, Can‐Karabulut, & Kalender, 2011; Osmari et al, 2018; Suri et al, 2016; Talesara, Kulloli, Shetty, & Kathariya, 2014; Vieira, Passos, de Assis, Mendonca, & Santiago, 2009; Yilmaz, Kurtulmus‐Yilmaz, & Cengiz, 2011) were ultimately included in the meta‐analysis. Of these included studies, eight (Abed et al, 2012; Bal et al, 2015; Chebel et al, 2018; Osmari et al, 2018; Suri et al, 2016; Talesara et al, 2014; Vieira et al, 2009; Yilmaz et al, 2011) and five (Guo et al, 2019; Kara & Orbak, 2009; Kumar & Mehta, 2005; Maximiano et al, 2019; Orhan et al, 2011) studies had split‐mouth and parallel designs, respectively.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…After duplicate exclusion and abstract screening, 37 studies were left for full‐text evaluation. Thirteen studies (Abed et al, 2012; Bal, Keskiner, Sezer, Acikel, & Saygun, 2015; Chebel, Zogheib, Baba, & Corbani, 2018; Guo, Kayastha, Chen, Shakya, & Chen, 2019; Kara & Orbak, 2009; Kumar & Mehta, 2005; Maximiano et al, 2019; Orhan, Aksoy, Can‐Karabulut, & Kalender, 2011; Osmari et al, 2018; Suri et al, 2016; Talesara, Kulloli, Shetty, & Kathariya, 2014; Vieira, Passos, de Assis, Mendonca, & Santiago, 2009; Yilmaz, Kurtulmus‐Yilmaz, & Cengiz, 2011) were ultimately included in the meta‐analysis. Of these included studies, eight (Abed et al, 2012; Bal et al, 2015; Chebel et al, 2018; Osmari et al, 2018; Suri et al, 2016; Talesara et al, 2014; Vieira et al, 2009; Yilmaz et al, 2011) and five (Guo et al, 2019; Kara & Orbak, 2009; Kumar & Mehta, 2005; Maximiano et al, 2019; Orhan et al, 2011) studies had split‐mouth and parallel designs, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…The study included 1,053 teeth with DH, and of these, 280, 232 and 541 teeth were treated with Nd:YAG laser, diode laser and topical desensitising agents, respectively. Seven studies (Abed et al, 2012; Chebel et al, 2018; Guo et al, 2019; Kara & Orbak, 2009; Kumar & Mehta, 2005; Maximiano et al, 2019; Talesara et al, 2014) compared Nd:YAG laser with conventional treatment using topical desensitising agents; the remaining six studies (Bal et al, 2015; Orhan et al, 2011; Osmari et al, 2018; Suri et al, 2016; Vieira et al, 2009; Yilmaz et al, 2011) compared diode laser with topical desensitising agents. We found no eligible studies of participants receiving other types of laser treatments such as Er:YAG and CO 2 lasers.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Few studies evaluate desensitizing products based on calcium and phosphate [47]. No studies assess the CPP-ACPF+PBM association in the DH treatment, hindering the results comparison with the literature [27].…”
Section: Discussionmentioning
confidence: 99%
“…The severity of symptoms does not depend on the breadth and depth of lesions, but on the number of non-occluded tubules exposed to the oral cavity, consequently the sealing of exposed and patent tubules should reduce or eliminate the pain and discomfort of the patient. Several treatments belonging to the tubule-occluding agent family [5] have been proposed including protein binding and calcium compounds deposition within tubules with casein phosphopeptide [6], peritubular mineral deposition and sodium uoride (NaF). Unfortunately, these treatments, as well as the use of nerve depolarization therapies (topical potassium nitrate), could be ineffective or might produce short-lived desensitizing effects [7].…”
Section: Introductionmentioning
confidence: 99%